Discovery of Novel 2-(piperidin-4-yl)-1H-benzo[d]imidazole Derivatives as Potential Anti-Inflammatory Agents

被引:16
作者
Li, Qing [1 ]
Hu, Qinghua [2 ]
Wang, Xinning [1 ]
Zong, Yang [1 ]
Zhao, Leilei [1 ]
Xing, Junhao [1 ]
Zhou, Jinpei [3 ]
Zhang, Huibin [1 ,2 ]
机构
[1] China Pharmaceut Univ, Ctr Drug Discovery, Nanjing 210009, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China
[3] China Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R China
关键词
2-(piperidin-4-yl)-1H-benzo[d]imidazole derivatives; anti-inflammatory activity; benzimidazole; inflammation; BENZIMIDAZOLE DERIVATIVES; NITRIC-OXIDE; RECEPTOR ANTAGONISTS; BIOLOGICAL-ACTIVITY; THERAPEUTIC USE; INHIBITORS; INFLAMMATION; DESIGN; AGONISTS; DISEASE;
D O I
10.1111/cbdd.12513
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel 2-(piperidin-4-yl)-1H-benzo[d]imidazole derivative 5 with good anti-inflammatory activity was identified from our in-house library. Based on hit compound 5, two series of 2-(piperidin-4-yl)-1H-benzo[d]imidazole derivative 6a-g and 7a-h were designed and synthesized as novel anti-inflammatory agents. Most of synthesized compounds exhibited good inhibitory activity on NO and TNF- production in LPS-stimulated RAW 264.7 macrophages, in which the compound 6e showed most potent inhibitory activity on NO (IC50=0.86m) and TNF- (IC50=1.87m) production. Further evaluation revealed that compound 6e displayed more potent in vivo anti-inflammatory activity than ibuprofen did on xylene-induced ear oedema in mice. Additionally, Western blot analysis revealed that compound 6e could restore phosphorylation level of IB and protein expression of p65 NF-B in LPS-stimulated RAW 264.7 macrophages.
引用
收藏
页码:509 / 516
页数:8
相关论文
共 33 条
[1]   Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors [J].
Alpan, Ayse Selcen ;
Parlar, Sulunay ;
Carlino, Luca ;
Tarikogullari, Ayse Hande ;
Alptuzun, Vildan ;
Gunes, Hasan Semih .
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (17) :4928-4937
[2]   Identification of novel benzimidazole derivatives as inhibitors of leukotriene biosynthesis by virtual screening targeting 5-lipoxygenase-activating protein (FLAP) [J].
Banoglu, Erden ;
Caliskan, Burcu ;
Luderer, Susann ;
Eren, Gokcen ;
Ozkan, Yagmur ;
Altenhofen, Wolfram ;
Weinigel, Christina ;
Barz, Dagmar ;
Gerstmeier, Jana ;
Pergola, Carlo ;
Werz, Oliver .
BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (12) :3728-3741
[3]   Nitric oxide and the immune response [J].
Bogdan, C .
NATURE IMMUNOLOGY, 2001, 2 (10) :907-916
[4]   Imidazole and benzimidazole derivatives as chemotherapeutic agents [J].
Boiani, M ;
González, M .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (04) :409-424
[5]   DICLOFENAC SODIUM - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN RHEUMATIC DISEASES AND PAIN OF VARYING ORIGIN [J].
BROGDEN, RN ;
HEEL, RC ;
PAKES, GE ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1980, 20 (01) :24-48
[6]   Targeting cannabinoid agonists for inflammatory and neuropathic pain [J].
Cheng, Yuan ;
Hitchcock, Stephen A. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (07) :951-965
[7]   Preclinical pharmacology of bilastine, a new selective histamine H 1 receptor antagonist: Receptor selectivity and in Vitro antihistaminic activity [J].
Corcóstegui R. ;
Labeaga L. ;
Innerárity A. ;
Berisa A. ;
Orjales A. .
Drugs in R & D, 2005, 6 (6) :371-384
[8]   Targeting inflammation using selective glucocorticoid receptor modulators [J].
De Bosscher, Karolien ;
Haegeman, Guy ;
Elewaut, Dirk .
CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (04) :497-504
[9]   ANTICYTOKINE STRATEGIES IN THE TREATMENT OF THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME [J].
DINARELLO, CA ;
GELFAND, JA ;
WOLFF, SM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (14) :1829-1835
[10]   Anti-inflammatory Agents: Present and Future [J].
Dinarello, Charles A. .
CELL, 2010, 140 (06) :935-950